Get the Stockscreener App
130.67
0.13%
-0.17
Pre-market:
130.01
-0.66
-0.51%
Overview
News
Price History
Option Chain
Financials
Why KMB Down?
Discussions
Forecast
Stock Split
Dividend History
Kimberly Clark Corp stock is traded at $130.67, with a volume of 1.99M.
It is down -0.13% in the last 24 hours and down -6.04% over the past month.
With more than half of its sales from personal care and another third from consumer tissue products, Kimberly-Clark is a leading manufacturer in the tissue and hygiene realm. Its brand mix includes Huggies, PullUps, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates in the professional segment, partnering with businesses to provide safety and sanitary offerings for the workplace. Kimberly-Clark generates just over half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America.
See More
Previous Close:
$130.84
Open:
$131.09
24h Volume:
1.99M
Relative Volume:
0.87
Market Cap:
$44.03B
Revenue:
$19.75B
Net Income/Loss:
$2.47B
P/E Ratio:
17.80
EPS:
7.34
Net Cash Flow:
$2.39B
1W Performance:
-1.52%
1M Performance:
-6.04%
6M Performance:
-0.53%
1Y Performance:
-6.32%
1-Day Range:
$130.41
$131.83
1-Week Range:
$130.41
$134.00
52-Week Range:
$124.10
$150.45
Kimberly Clark Corp Stock (KMB) Company Profile
Name
Kimberly Clark Corp
Sector
Industry
Phone
(972) 281-1200
Address
351 PHELPS DRIVE, IRVING, TX
Compare KMB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KMB
Kimberly Clark Corp
|
130.67 | 44.03B | 19.75B | 2.47B | 2.39B | 7.34 |
|
PG
Procter Gamble Co
|
160.88 | 381.13B | 83.93B | 15.50B | 15.03B | 6.30 |
|
UL
Unilever Plc Adr
|
62.78 | 153.91B | 65.10B | 6.16B | 0 | 2.4569 |
|
CL
Colgate Palmolive Co
|
90.11 | 73.64B | 19.95B | 2.90B | 3.47B | 3.54 |
|
KVUE
Kenvue Inc
|
21.65 | 40.89B | 15.30B | 1.06B | 1.45B | 0.55 |
Kimberly Clark Corp Stock (KMB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-08-25 | Downgrade | TD Cowen | Buy → Hold |
| Jul-23-24 | Initiated | TD Cowen | Buy |
| Jun-24-24 | Initiated | Exane BNP Paribas | Neutral |
| Jun-13-24 | Upgrade | BofA Securities | Underperform → Buy |
| Jun-03-24 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Mar-28-24 | Upgrade | Evercore ISI | In-line → Outperform |
| Mar-01-24 | Resumed | Goldman | Buy |
| Dec-15-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Nov-17-23 | Initiated | Piper Sandler | Overweight |
| Oct-12-23 | Upgrade | Bernstein | Underperform → Mkt Perform |
| Sep-22-23 | Initiated | HSBC Securities | Hold |
| Mar-20-23 | Upgrade | Deutsche Bank | Sell → Hold |
| Feb-17-23 | Initiated | Citigroup | Sell |
| Jan-04-23 | Downgrade | Jefferies | Buy → Hold |
| Dec-06-22 | Downgrade | Deutsche Bank | Hold → Sell |
| Oct-18-22 | Initiated | Evercore ISI | In-line |
| Oct-12-22 | Upgrade | Atlantic Equities | Neutral → Overweight |
| Sep-14-22 | Resumed | BofA Securities | Neutral |
| Feb-02-22 | Downgrade | Bernstein | Mkt Perform → Underperform |
| Jan-27-22 | Reiterated | Citigroup | Sell |
| Jan-27-22 | Reiterated | RBC Capital Mkts | Sector Perform |
| Jan-27-22 | Reiterated | UBS | Neutral |
| Jan-27-22 | Reiterated | Wells Fargo | Equal Weight |
| Jan-11-22 | Downgrade | Exane BNP Paribas | Outperform → Neutral |
| Oct-26-21 | Downgrade | Berenberg | Buy → Hold |
| Sep-09-21 | Initiated | HSBC Securities | Hold |
| Jun-24-21 | Initiated | UBS | Neutral |
| May-14-21 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Mar-19-21 | Downgrade | JP Morgan | Neutral → Underweight |
| Jan-26-21 | Downgrade | Argus | Buy → Hold |
| Jan-20-21 | Initiated | Bernstein | Mkt Perform |
| Dec-08-20 | Initiated | Wells Fargo | Underweight |
| Oct-16-20 | Initiated | Berenberg | Buy |
| Oct-16-20 | Downgrade | JP Morgan | Overweight → Neutral |
| Mar-30-20 | Upgrade | Jefferies | Hold → Buy |
| Oct-23-19 | Upgrade | Deutsche Bank | Sell → Hold |
| Sep-27-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Sep-23-19 | Upgrade | Barclays | Equal Weight → Overweight |
| Jul-24-19 | Upgrade | Atlantic Equities | Underweight → Neutral |
| Jun-19-19 | Reiterated | BofA/Merrill | Neutral |
| Apr-23-19 | Upgrade | Argus | Hold → Buy |
| Apr-23-19 | Upgrade | Macquarie | Neutral → Outperform |
| Feb-11-19 | Initiated | Exane BNP Paribas | Outperform |
| Jan-24-19 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Jan-18-19 | Upgrade | JP Morgan | Neutral → Overweight |
| Oct-08-18 | Downgrade | Goldman | Buy → Neutral |
| Sep-20-18 | Initiated | Atlantic Equities | Underweight |
| Aug-16-18 | Upgrade | JP Morgan | Underweight → Neutral |
| Aug-15-18 | Downgrade | Societe Generale | Buy → Hold |
| Jun-21-18 | Initiated | Morgan Stanley | Underweight |
| Dec-14-17 | Initiated | Deutsche Bank | Hold |
View All
Kimberly Clark Corp Stock (KMB) Latest News
How Cadence Bank, Kimberly-Clark, And Robert Half Can Put Cash In Your Pocket - Benzinga
Incontinence Pads Market Top PlayersCardinal Health Inc., - openPR.com
Kimberly-Clark Sells Global Tissue Unit in $3.4 Billion Deal - MSN
Warren Approves JEDD for Kimberly-Clark Project - Business Journal Daily
Warren, Howland Plan Public Hearings on Kimberly-Clark JEDD - Business Journal Daily
How Is Kimberly-Clark's Stock Performance Compared to Other Consumer Defensive Stocks? - Barchart.com
An Empire Built on Paper Looks to Benefit From Trump’s Trade War - Bloomberg.com
Jim Cramer Praises Kimberly-Clark’s (KMB) Deal with Suzano - Insider Monkey
Tesla And Lululemon Are Among Top 10 Large-Cap Losers Last Week (Jun 2-Jun 6): Are The Others In Your Portfolio? - Benzinga
15 Stocks on Jim Cramer’s Radar - Insider Monkey
Kimberly-Clark Nears Global Tissue Business Sale, WSJ Says - MSN
Suzano’s rating outlook revised to positive by S&P after Kimberly-Clark deal - Investing.com South Africa
2 Dividend Kings Reshaping Their Empires—Here's The Hidden Opportunity - 24/7 Wall St.
Suzano & Kimberly-Clark to Form Global Tissue Joint Venture - Nasdaq
Kimberly-Clark (KMB) Set to Divest Global Tissue Unit to Refocus Portfolio - MSN
Kimberly-Clark Teams Up With Suzano In $3.4 Billion Venture - Finimize
Kimberly-Clark Nears $3.5 Billion Sale of International Tissue B - GuruFocus
Kimberly-Clark to sell international Kleenex business, other tissue assets for $3.4 billion - The Business Journals
Kimberly-Clark Sells Stake in $3.4B Tissue Business to Suzano - USA Herald
Suzano stock soars on joint venture news; Kimberly-Clark dips - Investing.com
Tissue Titans Unite: Suzano, Kimberly-Clark Form $3.4 Billion Global JV - Benzinga
Kimberly-Clark (KMB) Announces Strategic Joint Venture with Suzano S.A. - GuruFocus
Kimberly-Clark To Sell Majority of $3.4B Global Tissue Business - Yahoo Finance
Irving-based Kimberly-Clark selling international arm for $3.4B - Dallas News
Kimberly-Clark Points Downward on Suzano Hookup - Baystreet.ca
Kimberly-Clark (KMB) Partners with Suzano for Global Tissue Vent - GuruFocus
suzano announces joint venture with kimberly-clark - Investing.com
Kimberly-Clark and Suzano form a new global tissue company that plays to their strengths (KMB:NASDAQ) - Seeking Alpha
Kimberly-Clark sells majority stake in international tissue unit to Brazil's Suzano - CNBC
Kimberly-Clark forms strategic partnership with Suzano for tissue and professional products - Investing.com
Suzano and Kimberly-Clark form $3.4 billion tissue venture - Investing.com
Kimberly-Clark to form partnership with Suzano - TipRanks
Kimberly-Clark (KMB) Forms Strategic Alliance with Suzano | KMB Stock News - GuruFocus
Kimberly-Clark to sell international tissue business in $3.4 billion deal By Reuters - Investing.com
Massive $3.4B Deal: Suzano Acquires 51% of Kleenex International Operations Across 70 Countries - Stock Titan
Kimberly-Clark to spin off Kleenex and other tissue products outside US - Financial Times
Kimberly-Clark's $3.4B Deal: Major Shift to High-Margin Personal Care as Tissue Unit Joins Suzano - Stock Titan
Kimberly-Clark (KMB) Nears Sale of Kleenex Division Outside Nort - GuruFocus
Kimberly-Clark (KMB) Nears Sale of Kleenex Division Outside North America | KMB Stock News - GuruFocus
Kimberly-Clark close to $3.5B sale of international Kleenex business, WSJ says - TipRanks
American National Bank & Trust Trims Holdings in Kimberly-Clark Co. (NYSE:KMB) - MarketBeat
Kimberly-Clark Co. (NYSE:KMB) Shares Acquired by Allied Investment Advisors LLC - MarketBeat
Kimberly-Clark Nears $3.5 Billion Sale of International Tissue Business - GuruFocus
Kimberly-Clark nears sale of Kleenex division outside North America for $3.5 billionreport - Investing.com
Kimberly-Clark (KMB) Nears $3.5B Sale of Tissue Business to Suza - GuruFocus
Kimberly-Clark nears $3.5B sale of international tissue business to SuzanoWSJ (KMB:NASDAQ) - Seeking Alpha
Kimberly-Clark nears $3.5 billion sale of global tissue business to Suzano, WSJ reports By Reuters - Investing.com
Kimberly-Clark nears $3.5 billion sale of global tissue business to Suzano, WSJ reports - Yahoo Finance
Kimberly Clark Corp Stock (KMB) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.17%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):